a developer of mechanism-targeted drugs to treat human cancers
Industry Biotechnology
A.I.dvisor tells us that CYCC and ONPPF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCC and ONPPF's prices will move in lockstep.
Ticker / NAME | Correlation To CYCC | 1D Price Change % | ||
---|---|---|---|---|
CYCC | 100% | +7.11% | ||
ONPPF - CYCC | 23% Poorly correlated | N/A | ||
BPTSY - CYCC | 21% Poorly correlated | -16.71% | ||
NGENF - CYCC | 21% Poorly correlated | -5.87% | ||
ATNF - CYCC | 21% Poorly correlated | N/A | ||
GNPX - CYCC | 21% Poorly correlated | -2.86% | ||
More |